CGON Competitors & Alternatives
Compare CG Oncology, Inc. Common stock with similar stocks in the same industry
Biotechnology
CGON
Main Stock$65.73
Tradestie Score
55
Market Cap
$3.01B
Revenue Growth
19.8%
Analyst Upside
+37.4%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CYTK
Cytokinetics Inc.
|
$80.01
|
$6.68B | - | 62 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$106.19
|
$6.64B | - | 65 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$98.43
|
$6.38B | - | 54 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$29.30
|
$6.03B | - | 52 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$53.99
|
$6.02B | - | 59 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.44
|
$5.95B | - | 60 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$241.97
|
$5.92B | - | 59 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$53.94
|
$5.80B | 19.0 | 57 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$340.21
|
$5.20B | 46.2 | 60 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$51.96
|
$4.94B | - | 60 | Compare |
More CGON Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2836)
224 stocks in this industry